Search alternatives:
significantly improved » significantly increased (Expand Search)
improved decrease » improved urease (Expand Search)
marked decrease » marked increase (Expand Search)
improved kinase » improves disease (Expand Search)
Showing 1 - 20 results of 23,885 for search '(( significantly ((improved decrease) OR (marked decrease)) ) OR ( significantly improved kinase ))', query time: 0.76s Refine Results
  1. 1
    miRNA 221 improved left ventricular contractile function in MIRI mice.

    miRNA 221 improved left ventricular contractile function in MIRI mice. by Hongyu Li (1332669)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function.

    Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function. by Anthony L. Gaeta (13272609)

    Published 2022
    Save to List
    Saved in:
  3. 3
    Environmental enrichment improves the social isolation induced learning impairment.

    Environmental enrichment improves the social isolation induced learning impairment. by Swamynathan Sowndharya (17816808)

    Published 2024
    Save to List
    Saved in:
  4. 4
    Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx

    Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx by Livia De Picker (8319105)

    Published 2020
    “…</p><p>Conclusion: The acute psychotic state is marked by state-specific increases of immune markers and decreases in peripheral IDO pathway markers. …”
    Save to List
    Saved in:
  5. 5
    Enrichment analyses of genes significantly changed following acute overexpression of Yhp1, Yhp1-13A, Yox1 or Yox1-9A.

    Enrichment analyses of genes significantly changed following acute overexpression of Yhp1, Yhp1-13A, Yox1 or Yox1-9A. by Michelle M. Conti (13514386)

    Published 2022
    Save to List
    Saved in:
  6. 6
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 7
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 8
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 9
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 11
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 12
    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS.

    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Effect of BM-MSCs in improving DCS induced lung injury.

    Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Lifespan curves of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in four groups.

    Lifespan curves of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 15
    Relative abundance of <i>Acetobacter</i>, <i>Wolbachia</i>, and <i>Lactobacillus</i> in the four groups.

    Relative abundance of <i>Acetobacter</i>, <i>Wolbachia</i>, and <i>Lactobacillus</i> in the four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 16
    S1 Data -

    S1 Data - by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 17
    Gut microbiota diversity indices of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in the four groups.

    Gut microbiota diversity indices of <i>InR</i><sup>[E19]</sup>/TM2 <i>D</i>. <i>melanogaster</i> in the four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 18
    Fig 7 -

    Fig 7 - by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 19
    Body weight of <i>InR</i><sup>[E19]/</sup>TM2 <i>D</i>. <i>melanogaster</i> on days 10 (10D), 20 (20D), and 30 (30D) in the four groups.

    Body weight of <i>InR</i><sup>[E19]/</sup>TM2 <i>D</i>. <i>melanogaster</i> on days 10 (10D), 20 (20D), and 30 (30D) in the four groups. by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 20
    Fig 3 -

    Fig 3 - by Denghui Wang (10275794)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: